# Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence

Study · id `cardio:ct-nct06644339` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06644339](<https://clinicaltrials.gov/study/NCT06644339>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06644339

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: High blood pressure; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

## Technical summary

Registry record NCT06644339. Non-randomized; no masking; primary purpose treatment. Start 2024-10-15 (anticipated); primary completion 2025-02-28 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT06644339, source copy `cardio:ctgov-nct06644339-2024-10-16`, retrieved 2026-11-18)
- Planned start: 2024-10-15 (anticipated) (ClinicalTrials.gov record NCT06644339, source copy `cardio:ctgov-nct06644339-2024-10-16`, retrieved 2026-11-18)
- Primary completion: 2025-02-28 (anticipated) (ClinicalTrials.gov record NCT06644339, source copy `cardio:ctgov-nct06644339-2024-10-16`, retrieved 2026-11-18)
- Completion: 2025-04-30 (anticipated) (ClinicalTrials.gov record NCT06644339, source copy `cardio:ctgov-nct06644339-2024-10-16`, retrieved 2026-11-18)
- Countries: Russia (ClinicalTrials.gov record NCT06644339, source copy `cardio:ctgov-nct06644339-2024-10-16`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06644339-2024-10-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence
- Acronym: DIALOG
- Condition: Heart Failure
- Condition: Diabetes Mellitus
- Condition: Arterial Hypertension
- Condition: Lymphoproliferative Disease
- Condition: Total Knee Replacement
- Intervention (Device): Voice assistant
- Lead sponsor: I.M. Sechenov First Moscow State Medical University
- Lead sponsor class: OTHER
- Collaborator: PJSC VimpelCom
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: I.M. Sechenov First Moscow State Medical University (`cardio:org-i-m-sechenov-first-moscow-state-medical-university`)

## Provenance

Content hash: 6e1344f85c899d6b8d738431c0a2c85a734d8100a330e38591c3dd1f4e86a1a0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
